Buy GLOW Peptide Blend 70 mg in Australia
GLOW, a 70 mg three-peptide blend, costs $189.99 from Australian Research Peptides, which sells it in Australia to laboratories and researchers, in stock for same-business-day dispatch if paid before 12pm Sydney time. A published batch certificate confirms the identity and measured amount of all three peptides. GHK-Cu, a copper-carrying tripeptide, is most of it by mass. BPC-157 is a fifteen-residue chain studied against VEGFR2 and nitric oxide signalling in assays; TB-500 is the seven-residue actin-binding motif of thymosin beta-4. ARP ships to every state and territory, and GLOW is a trade name, not a specification. In vitro research purposes only.
Copper Peptide Research · Lyophilised Powder · Independently lab-tested · SKU 64918
$189.99
1
Presentation
70 mg per vial
Grade
Research Grade
Form
Lyophilised Powder
Category
Copper Peptide Research
Same-day dispatch on business-day orders completed before 12pm Sydney time, Mon–Fri
Tracked shipping Australia-wide ·typically 1–2 business days to most areas by Express Post · free post over $199, free Express over $299
Batch certificates — published in the COA library
For in vitro research purposes only. Not for human consumption. Not for animal consumption. This product is not a drug, food, cosmetic, or dietary supplement. ARP gives no usage, medical or therapeutic guidance of its own.
GLOW · 70 mg
$189.99
Browse all Copper Peptide Research
About GLOW
Every peptide in a GLOW vial comes out of preclinical research, and each has its own literature. BPC-157 is a fifteen-amino-acid chain examined in assays against VEGFR2 and nitric oxide signalling. TB-500 is the seven-amino-acid actin-binding motif of thymosin beta-4, and in mouse studies the fragment alone performed comparably to the full protein. GHK-Cu is a human tripeptide carrying a copper(II) ion. None of that is a result in a person.
GLOW is not a compound. It is the name this category uses for three peptides freeze-dried together into one vial: BPC-157, TB-500 and GHK-Cu. Sellers write it GLOW 70, GLOW-70 or GLOW blend. The name is a market label, not a specification. Two vials sold under it need not hold the same total, so read the compound list and the milligram figure instead of the word. ARP catalogues each of the three in its own right as well, and two of them again as a pair.
The split is published on this page as a nominal formulation: roughly 50 mg of GHK-Cu, with the remaining 20 mg shared between BPC-157 and TB-500, itemised under "What is in the vial". Those figures are the recipe. Where a batch certificate is published, it is an identity-and-amount analysis — all three peptides named, each with a measured figure for the batch it reports — and it describes that batch rather than the listing. The FAQ below says where each of them sits, and ARP holds the material here as a laboratory reagent for in vitro research purposes only.
What is in the vial
| Component | Amount per vial |
|---|---|
| BPC-157 | ~10 mg |
| TB-500 — a fragment corresponding to the actin-binding region of thymosin beta-4 | ~10 mg |
| GHK-Cu — the copper(II) complex of the GHK tripeptide | ~50 mg |
| Total | 70 mg per vial |
Content reviewed
Further reading: Peptide Types, Categories and Blends · Where Is the Best Place to Buy Peptides in Australia? · GLOW vs KLOW: What Is the Difference Between the Peptide Blends?
GLOW specifications, storage and shipping
- Compound: GLOW
- Also known as: BPC-157, TB-500 and GHK-Cu combination
- Class: Three-peptide blend
- Appearance: Lyophilised powder
- Sizes & SKUs: 70 mg (64918)
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: Research grade
- Testing: Independently lab-tested for identity and amount before release — the laboratory's report for this blend gives a measured amount for each peptide and no purity figure
- Identity confirmation: Mass spectrometry
- Certificates: issued by Janoshik, an independent laboratory, and published in the COA library
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
GLOW is independently lab-tested for identity and amount. The full laboratory report is published in the COA library. GLOW is tested by Janoshik, an independent laboratory, commissioned by the manufacturer rather than by Australian Research Peptides.
- GLOW 70 mg: measured content GHK-Cu 58.44 mg · TB-500 12.65 mg · BPC-157 12.46 mg · laboratory batch 2026-06 · analysed 23 June 2026
Business-day orders before 12pm Sydney time are dispatched the same day with tracked shipping. Standard delivery within Australia typically takes 2–5 business days. See Shipping & Delivery for details, and follow your parcel on the Track Order page.
For in vitro research purposes only. Not for human consumption. Not for animal consumption. Not a drug, food, cosmetic, or dietary supplement. No therapeutic or medical claims are made.
Questions about GLOW
This question guide from Australian Research Peptides covers GLOW in Australia: what the listing contains, live buying and delivery questions, research context, handling, testing and comparisons. Start with the quick answers, then open the topic group that matches your search.
Buying, price and availability
Australian Research Peptides supplies GLOW throughout Australia — one 70 mg vial combining BPC-157, TB-500 and GHK-Cu, catalogued under the GLOW code and reached by searching "glow blend". Weekday orders confirmed before 12pm Sydney time are packed and posted that same afternoon from Sydney, so no parcel meets customs. Express Post and standard tracked services reach every state and territory. GLOW is independently lab-tested for identity and amount, ARP publishes the certificate in its CoA library, and payment is by PayID or bank transfer.
GLOW seldom prompts this worry. Seventy milligrams of combined solid is ample to see, and its GHK-Cu component tints the whole mass blue, so expect a coloured chalky body rather than an invisible layer. The three peptides dry as one and are not visible as separate bands. A cake sitting unevenly, or cracked from handling, changes nothing about the contents.
GLOW is supplied by Australian Research Peptides, which supplies the three-peptide vial from within Australia and takes orders online rather than by phone or counter. PayID and bank transfer are the payment methods accepted; wallets, instalment accounts and crypto are not taken at all. Delivery is by domestic post to any Australian address.
A GLOW order takes 2–5 business days to travel by standard tracked post, or 1–2 on Express Post into the faster states. One 70 mg vial holds three peptides, so what would otherwise be three parcels is one. Anything else on the same order, such as another vial, is packed into that same satchel under a single tracking number.
A 70 mg GLOW vial needs more diluent than a single 10 mg peptide for the same concentration, because volume is worked out from milligrams and GLOW holds 70 of them. One GLOW vial replaces three, but it does not reduce the diluent needed, and Australian Research Peptides publishes no fill volume for it.
Identity, names and exact format
GLOW is a market label for a three-peptide blend of BPC-157, TB-500 and GHK-Cu; the four letters do not stand for a published expansion. Australian Research Peptides uses GLOW as the catalogue label rather than an abbreviation. Because the name is not a specification, two products sold as GLOW need not match: compare the compounds named and the total quantity.
GLOW has no single amino-acid count, because the vial holds three separate chains. BPC-157 is a pentadecapeptide, fifteen amino acids long (PubChem). The TB-500 fragment is seven. The GHK part of GHK-Cu is three, and its copper is bound to that chain rather than counted as a fourth unit. Three chains, three counts, one vial.
Combining three peptides in a GLOW vial is a packaging decision, not a scientific finding. Each compound has its own separate literature, and no published study has examined the three together. Australian Research Peptides does not claim the three behave differently together than apart. What the format saves is handling.
One GLOW vial replaces three separate vials, and the honest comparison is its price against what BPC-157, TB-500 and GHK-Cu come to bought individually from Australian Research Peptides. What the blend costs you is flexibility — the ratio between the three peptides is fixed in the vial, so it cannot be adjusted the way three separate vials can.
GLOW's colour comes from its GHK-Cu component — copper complexes are pigmented, which is unusual among peptides and catches people out on first opening a vial. Expect blue in the dry cake and blue in solution. A GLOW preparation showing no colour at all is the one that raises a question about what is in it.
One storage decision covers all three of GLOW's peptides, because they share a vial. Keep the sealed powder dry, below -15 °C and away from direct light — the copper complex is the light-sensitive part, and it is most of the cake. Peptides pull moisture out of the air, so let the vial warm up inside a desiccator — a sealed container holding a drying agent — before breaking the seal. Bachem advises splitting any solution into portions and freezing them rather than keeping one volume.
GLOW is one vial, not three, and all three peptides sit in the same freeze-dried powder. Nothing arrives as a boxed set of separate vials. The glass is sealed and tamper-evident. Because the peptides share a container, the whole vial takes one storage decision and one mixing step rather than three of each, and the proportions between them are fixed at blending.
GLOW carries a third peptide that the BPC-157 + TB-500 vial does not, and it is GHK-Cu. The two listings also carry different totals per vial. They are separate products with separate stock, not two sizes of one thing. Judge them on the compounds listed and the milligrams in the vial rather than on which name looks bigger.
Research context and evidence
GLOW is a ready-blended combination of three peptides examined in cell-signalling and extracellular-matrix research, supplied by Australian Research Peptides to laboratories and researchers as a single 70 mg vial. Inside it are GHK-Cu, much the largest share by mass, together with BPC-157 and TB-500. GHK-Cu is a copper tripeptide that occurs naturally in people (Maquart 1988) and the part that colours the cake blue. BPC-157 is examined against inflammatory and vascular signalling in animal models. TB-500 is examined for cell migration and new blood-vessel formation in mouse models. The three are studied against three separate mechanisms, in cells and animals rather than in people, and the milligram figures beside each name are the formulation the blend is made to rather than an assay of the glass you receive.
GLOW 70 mg lyophilized peptide is the freeze-dried three-peptide blend — GHK-Cu, BPC-157 and TB-500 — sealed in one vial and supplied by Australian Research Peptides for laboratory research. Lyophilised and lyophilized are the same word in British and American spelling: the solution is frozen and the water drawn off under vacuum, leaving a dry cake that keeps until it is mixed. The 70 mg is the combined mass of all three peptides rather than the mass of any one of them, so a 70 mg blend and a 70 mg single-compound vial are not comparable quantities. Listings also write the same product GLOW 70 and GLOW-70.
GLOW has three mechanisms under study, one per peptide, and none of them is settled. BPC-157 is examined in cell and animal work for its interaction with VEGFR2 and with nitric oxide signalling. TB-500 is the seven-residue actin-binding motif of thymosin beta-4, and peptides missing part of that motif were inactive in binding assays (Philp 2003). GHK-Cu binds a copper(II) ion inside its three-residue chain, at an affinity the literature compares with the copper transport site on albumin.
GLOW's component studies measure effects on cells, not on people. GHK-Cu is studied for signalling cultured fibroblasts to make collagen and elastin. BPC-157 is studied against inflammatory signalling in animal models. TB-500 is studied for cell migration and the formation of new blood vessels. The published work reports what happens to those cells; it does not report a result in a person. GLOW is sold to laboratories and researchers as a research material. No cosmetic or medical effect is claimed for it.
The research behind GLOW is three separate bodies of work, one per peptide, and not one of them studied the vial. BPC-157 has been examined in animal work on blood-vessel signalling. The TB-500 fragment has been examined in mouse studies (Philp 2003). GHK-Cu carries the longest record of the three, in cell and animal work on collagen and elastin synthesis. No published study has tested the three together in one preparation, and Australian Research Peptides states that gap rather than filling it.
Most of the 70 mg in a GLOW vial is GHK-Cu — about 50 mg of it — and the remaining 20 mg is divided evenly between BPC-157 and TB-500. Those are the formulation figures the blend is made to rather than a measured result for the glass you receive, and the quantity on the label is the combined total for all three. Where a batch certificate is published, it reports a measured milligram figure for each of the three peptides; that measurement describes the batch tested, and for that batch it is the figure that counts rather than the recipe.
Australian Research Peptides lists GLOW in one size only, the 70 mg vial, so the comparison is with a smaller 50 mg blend bought elsewhere rather than with a second ARP listing. Seventy milligrams holds more of each of the three peptides than fifty does, which means fewer vials to prepare for the same quantity and less risk of running short partway through a piece of work. ARP's vial is blended at the standard GLOW ratio, most of its mass the copper peptide and the remainder split between the other two — the recipe figures rather than a laboratory measurement. GLOW is a market label rather than a specification, so a vial carrying the name elsewhere may hold a different total again; check what a seller states in milligrams before treating two listings as the same thing.
No, GLOW is not a protein powder, and it is not a food of any kind. Protein powder is a bulk dietary ingredient measured in grams and eaten. GLOW is a milligram quantity of three short synthetic peptides sealed in a laboratory vial. Australian Research Peptides supplies it for in vitro research, and it is not for consumption by anyone.
Buy GHK-Cu on its own when the copper tripeptide is the only compound wanted, and GLOW when BPC-157 and TB-500 are wanted alongside it. Australian Research Peptides lists both, and a GHK-Cu vial holds more of that one peptide than a GLOW vial does, because GLOW's 70 mg is shared three ways in proportions fixed when the cake is dried. The two also sit differently under Australian law: GHK-Cu is the one of the three that is not scheduled, so the blend brings a regulatory position with it that a single copper-peptide vial does not.
Handling, storage and measurements
Reconstituting GLOW puts all three peptides into solution at once, since they were dried together. Send the diluent against the glass, never onto the powder. Swirl the vial gently rather than shaking it, and wait until the liquid runs clear. Bachem notes that dissolving a peptide can occasionally take several hours.
A GLOW vial holds 70 mg across three peptides, so any concentration worked out from the volume added is a combined figure for all three and never the strength of one of them. One volume takes all three into solution because they were dried together, and the proportions between them stay as blended whatever goes in. Australian Research Peptides sets no fill volume for a GLOW vial: that is a bench decision, and the 70 mg of solid does not change with it.
GLOW in solution is worked through inside twelve weeks, refrigerated between 2 and 8 degrees Celsius — Australian Research Peptides' general figure rather than a measured one, since no published study has followed three peptides sharing a single vial. GLOW is also the only ARP blend placing a bound copper ion beside two plain peptide chains, which argues for the short end.
Colour and clarity are separate properties, and GLOW's GHK-Cu fraction makes the liquid blue while leaving it perfectly see-through; opacity is what indicates trouble. Because three peptides take up water at unequal rates, a short hazy interval while the slowest finishes is expected, and shaking beats in air on top of that. Allow ten quiet minutes before judging.
GLOW needs a diluent, because the vial holds dry powder and nothing else. A diluent takes dry material into solution, and one volume of it covers all three of GLOW's peptides. An aqueous diluent is the one ordinarily chosen for work of this kind, and none travels with a GLOW vial.
GLOW is a three-peptide blend — BPC-157, TB-500 and GHK-Cu in a single 70mg vial — supplied by Australian Research Peptides Pty Ltd, which trades as ARP. The GLOW blend is independently lab-tested for identity and amount. Nothing crosses a border. Beat the 12pm Sydney time cut-off on a business day and the vial is lodged that afternoon, on either postage service, to any address the carrier reaches.
A GLOW vial carries one Australian-dollar figure covering all three peptides at once. Setting that against a single-compound page compares a three-peptide vial with a one-peptide vial, which is not a like-for-like read. The fairer comparison is another blend of stated total quantity. Postage is charged on top and is quoted separately.
One GLOW vial earns free Standard tracked post on its own — true of only a handful of Australian Research Peptides lines, and a consequence of it holding three peptides rather than one. It does not reach the higher Express Post threshold, so choosing Express on a single-vial order still adds a fee. Adding a second compound does not affect the standard entitlement.
Testing and batch documents
Written as glow70, GLOW-70 or GLOW 70mg, these are the same 70 mg vial of three peptides, and the number is simply the total milligrams in the cake rather than part of a compound name. Buyers also type gkp70, a near-miss for the GHK in GHK-Cu, the peptide that makes up most of the vial by mass. Whichever way it is typed, the contents are the ones named on this page: BPC-157, TB-500 and GHK-Cu.
Ordering, payment and Australian delivery
Pay a GLOW order to the cent. A PayID or bank transfer is typed by hand, so an amount that does not match the order total has to be reconciled by hand too, and a short payment cannot release the stock at all. If you have underpaid or overpaid, contact support with the reference rather than sending a second transfer, which creates two unmatched payments instead of one.
Not one of GLOW's three peptides has ever been licensed as a medicine, so the combination holds no American approval and none anywhere else. Regulators assess a combination as a whole product, and no agency has assessed this one. Two of the three components are additionally scheduled under Australian law. The vial is a research reagent: unregistered, unreviewed, and not for a person.
GLOW is banned in sport, because two of its three peptides are: BPC-157 under the non-approved heading S0, and TB-500 with the growth factors under S2. GHK-Cu is named in neither, though that is not a clearance. Sport Integrity Australia administers that list in Australia, and a blend is assessed on every compound it contains.
GLOW is not registered as a medicine in Australia, and two of its three peptides are scheduled. GHK-Cu is on neither list and is most of the vial by mass, so the majority of what is in the glass is unscheduled while the minority sets the position for all of it. No regulator has assessed the mixture as a product. Australian Research Peptides supplies GLOW to laboratories and researchers as unregistered research material and gives no legal advice.
Access and regulatory questions
Importing GLOW is not a question an order from Australian Research Peptides raises, because the vials are held here and travel between two Australian addresses with nothing presented at a border. Bringing one in from overseas is a different matter, and a blend makes it harder rather than easier: a single parcel carries three compounds, two of them scheduled here, and the personal-importation rules are applied to each compound rather than to the label on the box. The customs step is the only part domestic supply removes — the compounds and the obligations attaching to them do not change with the postmark.
Yes, GLOW is independently lab-tested before Australian Research Peptides supplies it, commissioned by the manufacturer, and three peptides means three things to account for. The laboratory reports identity and amount: each of the three peptides named, with a measured milligram figure for each. The results are specific to the batch tested. A matching certificate is currently published for this product and strength. Open the 70 mg certificate.
GLOW carries no single purity percentage, because one number cannot describe a vial holding three different peptides. What a blend analysis reports instead is identity and amount: each compound named, with a measured milligram figure for it in the batch tested. A percentage belongs to a single-compound listing, where there is one molecule for it to describe. Averaging three components, or borrowing one component's certificate, would produce a figure no document supports, so Australian Research Peptides publishes neither. Treat a single purity percentage quoted for a three-peptide blend as a number with nothing behind it.
GLOW has no chemical synonym; it is a market label, written GLOW Blend, GLOW 70, GLOW-70 or GLOW 70mg depending on the seller. Australian Research Peptides uses GLOW as the catalogue code for its blend of BPC-157, TB-500 and GHK-Cu, and the compound-name form BPC TB GHK finds the same listing. Because GLOW is not a standardised scientific name, products with that label can differ between suppliers; compare the named components and quantities.